Results
1 -
3 of
3
(Click
here to explore results)
- The p53-MDM2/MDMX axis – A chemotype perspective. Kareem Khoury, Grzegorz M. Popowicz, Tad A. Holak, Alexander Dömling
, Med. Chem. Commun.
, 2011
, 2
, 246
- Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions. Tim J. Blackburn, Shafiq Ahmed, Christopher R. Coxon, Junfeng Liu, Xiaohong Lu, Bernard T. Golding, Roger J. Griffin, Claire Hutton, David R. Newell, Stephen Ojo, Anna F. Watson, Andrey Zaytzev, Yan Zhao, John Lunec, Ian R. Hardcastle
, Med. Chem. Commun.
, 2013
, 4
, 1297
- A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer. Jessica J. Miller, Christian Gaiddon, Tim Storr
, Chem. Soc. Rev.
, 2020
, 49
, 6995